HomeCompareEQMEF vs PFE

EQMEF vs PFE: Dividend Comparison 2026

EQMEF yields 900.90% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQMEF wins by $7634567.44M in total portfolio value
10 years
EQMEF
EQMEF
● Live price
900.90%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7634567.49M
Annual income
$6,266,297,597,749.10
Full EQMEF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — EQMEF vs PFE

📍 EQMEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEQMEFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EQMEF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EQMEF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EQMEF
Annual income on $10K today (after 15% tax)
$76,576.58/yr
After 10yr DRIP, annual income (after tax)
$5,326,352,958,086.73/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, EQMEF beats the other by $5,326,352,934,957.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EQMEF + PFE for your $10,000?

EQMEF: 50%PFE: 50%
100% PFE50/50100% EQMEF
Portfolio after 10yr
$3817283.77M
Annual income
$3,133,148,812,479.82/yr
Blended yield
82.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

EQMEF
No analyst data
Altman Z
44.9
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EQMEF buys
0
PFE buys
0
No recent congressional trades found for EQMEF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEQMEFPFE
Forward yield900.90%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$7634567.49M$51.1K
Annual income after 10y$6,266,297,597,749.10$27,210.54
Total dividends collected$7528407.85M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EQMEF vs PFE ($10,000, DRIP)

YearEQMEF PortfolioEQMEF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$100,790$90,090.09$9,161$701.38+$91.6KEQMEF
2$956,461$848,615.73$8,610$859.79+$947.9KEQMEF
3$8,549,631$7,526,217.92$8,366$1,081.25+$8.54MEQMEF
4$72,022,393$62,874,287.34$8,483$1,405.66+$72.01MEQMEF
5$572,068,813$495,004,852.85$9,084$1,907.24+$572.06MEQMEF
6$4,286,682,617$3,674,568,986.74$10,418$2,732.78+$4286.67MEQMEF
7$30,320,062,361$25,733,311,961.41$13,007$4,193.56+$30320.05MEQMEF
8$202,548,872,218$170,106,405,491.19$18,010$7,005.87+$202548.85MEQMEF
9$1,278,756,912,645$1,062,029,619,371.43$28,216$12,979.89+$1278756.88MEQMEF
10$7,634,567,494,279$6,266,297,597,749.10$51,081$27,210.54+$7634567.44MEQMEF

EQMEF vs PFE: Complete Analysis 2026

EQMEFStock

Equity Metals Corporation engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, zinc, copper, and diamond ores. It owns a 100% interest in the Silver Queen property consists of 17 crown-granted and 45 tenure claims covering an area of 18, 851.76 hectares located in the Omineca Mining Division, near Owen Lake, British Columbia; 57.49% interest in the Monument Diamond property located on the south shore of Lac de Gras in the Northwest Territories; and 100% in Saskatchewan Silica Sand lease covering an area of 54 acres. The company was formerly known as New Nadina Explorations Limited and changed its name to Equity Metals Corporation in September 2019. Equity Metals Corporation was incorporated in 1964 and is headquartered in Vancouver, Canada.

Full EQMEF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this EQMEF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EQMEF vs SCHDEQMEF vs JEPIEQMEF vs OEQMEF vs KOEQMEF vs MAINEQMEF vs JNJEQMEF vs MRKEQMEF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.